1, 2, 3 Rajarambapu College of Pharmacy, Kasegaon, Maharashtra, India
4, 5, 6, 7 Sahyadri College of pharmacy, Methwade, Sangola, Maharashtra, India
Phytosomes are advanced lipid-based vesicular systems designed to enhance the solubility, permeability, and bioavailability of plant-derived phytoconstituents. These nanocarriers overcome the limitations of traditional herbal delivery by forming lipid-compatible complexes, especially suitable for polyphenolic compounds like flavonoids. Various preparation techniques such as solvent evaporation, anti-solvent precipitation, thin film hydration, freeze-drying, and emerging technologies like spray-drying and supercritical fluid methods are employed to formulate phytosomes. Each method significantly influences the physicochemical and biological performance of the final product. This review provides an in-depth exploration of phytosome preparation methods, along with their mechanisms, advantages, and challenges, and includes comparative insights with other nanocarrier systems like liposomes and niosomes. Emphasis is placed on process optimization, clinical relevance, and integration of topical and oral phytosome applications.
Plant-derived bioactives, particularly polyphenols and flavonoids, are gaining attention due to their diverse therapeutic properties, such as antioxidant, hepatoprotective, anticancer, cardioprotective, and anti-inflammatory activities [1]. However, poor bioavailability and limited solubility hinder their clinical utility [2]. These compounds typically exhibit poor absorption due to large molecular size, poor lipophilicity, or instability in gastrointestinal fluids [3].
Fig.1 Phytosome Structure
Phytosomes, first developed by Indena (Italy) in the late 1980s, revolutionized herbal delivery systems by complexing bioactives with natural phospholipids, usually phosphatidylcholine, to form lipid-compatible molecular complexes [4]. Unlike liposomes, phytosomes are not just physical mixtures but molecular adducts that interact via hydrogen bonding and polar interactions [5]. This improves solubility and membrane permeability, thereby significantly increasing oral and topical bioavailability.
Clinical studies have demonstrated increased absorption and therapeutic efficacy of phytosomal formulations of silymarin, curcumin, green tea catechins, and ginkgo biloba extract [6]. Their applications span nutraceuticals, cosmetics, dermatology, and chronic disease treatment, including diabetes, cancer, and neurodegenerative disorders [7].
2. Advantages and Disadvantages of Phytosomes
2.1 Advantages
Phospholipid complexes offer several significant advantages in drug delivery systems. They enhance bioavailability due to their amphiphilic nature, allowing better interaction with both aqueous and lipid environments [8]. These complexes also improve the stability of labile phytochemicals in biological systems by protecting them from enzymatic and pH-related degradation [9]. Additionally, they facilitate better permeability, enabling easier transdermal and intestinal absorption of active compounds [10]. Their unique structure supports the dual encapsulation of both hydrophilic and lipophilic substances [11], contributing to reduced dose frequency through sustained release and improved pharmacokinetics [12]. In cosmetic applications, they enhance product appeal, particularly in skin and hair care formulations [13]. Furthermore, the synthesis of these complexes is eco-friendly, requiring fewer toxic solvents and lower energy input [14].
2.2 Disadvantages
Despite their advantages, phospholipid complexes also present certain limitations. Their formulation requires precise stoichiometric ratios between the phospholipid and the phytochemical to ensure effective complexation [15]. There is also a risk of thermal or oxidative degradation during the preparation process, which can compromise the integrity of the final product [16]. Inconsistency in raw materials may lead to batch-to-batch variability, affecting the reproducibility and reliability of the formulation [17]. Moreover, high production costs and challenges related to scalability pose significant barriers for industrial applications [18]. Additionally, these complexes often exhibit limited shelf stability, especially under conditions of high humidity or elevated temperatures [19].
3. Methods of Preparation of Phytosomes
3.1 Solvent Evaporation Method
One of the most commonly used methods, this technique involves dissolving both the phytoconstituent and phospholipid in an organic solvent such as ethanol, chloroform, or dichloromethane. The solution is then stirred and refluxed for several hours to allow complexation [20]. The solvent is subsequently evaporated using a rotary evaporator to obtain a thin film or dried mass.
Advantages: Simple, effective, and suitable for heat-stable compounds. Allows uniform molecular interaction.
Limitations: Not suitable for thermo-labile phytochemicals. Residual solvent may require complete removal [21].
Example: Silybin-phosphatidylcholine complex was successfully prepared by this method and showed 2.5x increased oral bioavailability [22].
3.2 Anti-Solvent Precipitation
Fig.2 Antisolvent Precipitation Method
In this method, the phospholipid–phytoconstituent mixture (prepared in an organic solvent) is poured into a non-solvent like n-hexane under constant stirring. This leads to precipitation of the complex due to polarity mismatch [23]. The precipitated phytosomes are filtered or centrifuged and dried.
Advantages: Suitable for heat-sensitive phytochemicals. Offers controlled particle formation.
Limitations: Difficult to scale up. Requires careful choice of anti-solvent and stirring rate.
Application: Used in green tea polyphenol phytosomes to enhance their solubility and antioxidant activity [24].
3.3 Thin Film Hydration Technique
The phytoconstituent and phospholipid are dissolved in a volatile solvent (chloroform: methanol), then evaporated under vacuum to form a thin lipid film. This is hydrated with aqueous media (e.g., phosphate-buffered saline), forming multilamellar vesicles [25]. Sonication or extrusion is applied to reduce size.
Advantages: Allows vesicle size control. Mimics liposome production, making it compatible with existing equipment.
Limitations: Time-consuming. Risk of oxidative degradation of bioactives during solvent removal.
Example: Quercetin-loaded phytosomes prepared by this method showed improved topical delivery and antioxidant activity [26].
3.4 Freeze-Drying (Lyophilization)
Involves freezing the phospholipid–phytoconstituent mixture followed by sublimation under vacuum. Cryoprotectants like trehalose or mannitol are often added to stabilize the vesicle structure [27].
Advantages: Results in a dry, stable powder with extended shelf-life. Useful for reconstitution.
Challenges: Requires expensive equipment and multiple process steps.
Application: Applied in curcumin phytosome formulations to enhance solubility and storage stability [28].
3.5 Miscellaneous and Emerging Methods
Spray-Drying: Offers fast, scalable powder production, suitable for capsule or tablet forms [29].
Supercritical Fluid Technology: Uses CO? to form solvent-free phytosomes, offering eco-friendly processing and uniform particle size [30].
Microfluidization: Forces liquids through microchannels to create uniform vesicles with narrow particle distribution [31].
Electrospinning and nanoemulsion-based techniques are also being explored for hybrid phytosome delivery [32].
3.6 Quality Control Parameters
4. Comparative Evaluation with Other Nanocarrier Systems
Feature |
Phytosomes |
Liposomes |
Niosomes |
Transferosomes |
Structure |
Phospholipid–drug complex |
Phospholipid bilayer vesicles |
Non-ionic surfactant vesicles |
Highly deformable vesicles |
Drug Binding |
Molecular complexation |
Passive entrapment |
Passive entrapment |
Passive entrapment |
Stability |
Higher chemical stability |
Moderate |
Variable |
High flexibility, moderate stability |
Skin Penetration |
Moderate to high |
Moderate |
Low |
Very high |
Scale-up Potential |
Moderate |
High |
High |
Low |
Use in Topicals |
Effective [35] |
Moderate |
Rare |
Excellent |
Example Drug |
Silymarin, Curcumin |
Amphotericin B |
Diclofenac |
Insulin, Leuprolide |
Phytosomes differ from liposomes and niosomes in that they involve true complex formation at the molecular level rather than mere encapsulation, resulting in better stability and controlled release [35].
Fig. No.3 Difference between Liposome, Niosome & Phytosome
SUMMARY
Phytosomes serve as a potent nanocarrier platform for overcoming the limitations of herbal actives with poor water solubility and permeability. Among the various preparation methods, solvent evaporation and thin film hydration remain widely adopted, while newer techniques such as microfluidization and supercritical fluid-based methods are advancing towards commercial viability.
Method selection depends on the phytochemical's properties, desired release profile, and final dosage form. Their application in topical delivery, particularly for skin disorders and anti-aging formulations, is expanding rapidly. Comparatively, phytosomes exhibit better stability and bioactive retention than traditional vesicular systems like liposomes or niosomes.
CONCLUSION
Phytosome technology has emerged as a transformative approach for enhancing the therapeutic efficacy of plant-based compounds. Proper method selection, stoichiometry, and process optimization are essential to achieve desirable pharmacokinetic and therapeutic outcomes. Future research should emphasize process standardization, regulatory alignment, and development of hybrid delivery systems combining phytosomes with polymers or nanoparticles.
The growing interest in green, cost-effective, and patient-compliant formulations makes phytosomes a strategic focus for both research and industry. Integration with modern nanotechnology tools will further expand their pharmaceutical applications in chronic diseases and personalized medicine.
REFERENCES
Shaunak Bele, Mangesh Bhutkar, Aarati Sawanji, Shantanu Bele, Priti Gurav, Mayur Pawar, Rohan Raut, From Plant to Pill: Exploring Phytosome Preparation Techniques and Their Therapeutic Potential, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 7, 4068-4075. https://doi.org/10.5281/zenodo.16608330